Elusive And Expensive: COVID-19 Life Saving Drugs

Covid-19 life-saving drugs Tocilizumab and Remdesivir are not easily available for relatives of patients who might need them.

How is a shortage of life-saving drugs against COVID-19 like Tocilizumab and Remdesivir pushing families of coronavirus patients to desperation? Relatives of COVID-19 positive patients say they are charged between Rs 31,500 - 72,000 to source a 400 mg vial of Tocilizumab on the black market.


If you value our work, we have an ask:

Our journalists work with TruthSeekers like you to publish fact-checks, explainers, ground reports and media literacy content. Much of this work involves using investigative methods and forensic tools. Our work is resource-intensive, and we rely on our readers to fund our work. Support us so we can continue our work of decluttering the information landscape.

BECOME A MEMBER
📧 Subscribe to our newsletter here.

📣You can also follow us on Twitter, Facebook, Instagram, Youtube, Linkedin and Google News
Show Full Article
Next Story